Skip to main content
. Author manuscript; available in PMC: 2005 Nov 23.
Published in final edited form as: J Clin Endocrinol Metab. 2005 Jan 5;90(4):2225–2232. doi: 10.1210/jc.2004-1365

Fig. 1.

Fig. 1

Experimental paradigm comprising separate-day, randomly ordered, fasting iv infusions of saline (A), l-arginine/GHRH (in tandem) (B), l-arginine/GHRP-2 (in tandem) (C), and constant combined GHRH/GHRP-2 (D) in healthy young adults. A maximally effective dose of each secretagogue was used to “clamp” correspondingly paired receptor-effector pathways (Subjects and Methods).